Latest news
-
04 September 2017 -
03 July 2017 Almac Discovery is Granted Orphan Drug Designation for ALM201 Programme in Ovarian Cancer
Read more
-
20 June 2017 Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor
Read more
-
08 May 2017 Almac Discovery Announce key Wee-1 kinase patent approval
Read more
-
14 February 2017 RCSI and Almac Discovery enter research collaboration to target therapy-resistant cancer tumours
Read more
-
30 May 2016 Almac Discovery, McClay Foundation and Ulster University join forces to explore diseases of the eye
Read more
-
04 February 2016 Almac Discovery Secures Patent Protection for Novel allosteric Akt inhibitor (ALM301)
Read more
-
05 October 2015 Almac Discovery Secures European Patent Protection for ALM201
Read more
-
10 July 2015 Almac Discovery Announce Ubiquitin Specific Protease Collaboration with Genentech
Read more